These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36291387)

  • 1. Clinical and Instrumental Follow-Up of Childhood Absence Epilepsy (CAE): Exploration of Prognostic Factors.
    Amianto F; Davico C; Bertino F; Bartolini L; Vittorini R; Vacchetti M; Vitiello B
    Children (Basel); 2022 Sep; 9(10):. PubMed ID: 36291387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of epilepsy with generalized tonic-clonic seizures alone: Clinical features, response to treatment, and likelihood of medication withdrawal.
    Jaafar F; Wazne J; Hmaimess G; Nasreddine W; Beydoun A; Shatila A; Beydoun A
    Epilepsia Open; 2024 May; ():. PubMed ID: 38819591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term prognosis for childhood and juvenile absence epilepsy.
    Trinka E; Baumgartner S; Unterberger I; Unterrainer J; Luef G; Haberlandt E; Bauer G
    J Neurol; 2004 Oct; 251(10):1235-41. PubMed ID: 15503104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of persistent interictal epileptiform discharges on antiseizure medication withdrawal in patients with epilepsy in five-year remission.
    Liang X; Yu N; Zhang YF; Gu L; Di Q
    Seizure; 2022 Jan; 94():100-106. PubMed ID: 34883461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of seizure relapse and long-term outcomes after discontinuation of antiseizure medication in children with epilepsy.
    Yıldırım M; Bektaş Ö; Kartal AT; Yeniay Süt N; Teber S
    Epilepsy Behav; 2022 Sep; 134():108779. PubMed ID: 35763995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-discontinuation of antiseizure medication in seizure-free epilepsy patients.
    Doerrfuss JI; Hüsing T; Graf L; Ilyas-Feldmann M; Holtkamp M
    Eur J Neurol; 2024 Mar; 31(3):e16160. PubMed ID: 38015451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical childhood absence epilepsy with preceding or simultaneous generalized tonic clonic seizures.
    Wakamoto H; Fukuda M; Shigemi R; Murakami Y; Motoki T; Ohmori H; Ishii E
    Brain Dev; 2011 Aug; 33(7):589-92. PubMed ID: 21041049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures.
    Glass HC; Soul JS; Chang T; Wusthoff CJ; Chu CJ; Massey SL; Abend NS; Lemmon M; Thomas C; Numis AL; Guillet R; Sturza J; McNamara NA; Rogers EE; Franck LS; McCulloch CE; Shellhaas RA
    JAMA Neurol; 2021 Jul; 78(7):817-825. PubMed ID: 34028496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for seizure recurrence after initial withdrawal of anti-seizure medications in children with epilepsy at Aga Khan University Hospital, Nairobi, Kenya.
    Odero N; Oyieke K; Gwer S; Samia P
    Epilepsy Behav Rep; 2023; 22():100596. PubMed ID: 37013158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural course and predictors of spontaneous seizure remission in idiopathic generalized epilepsy: 7-27 years of follow-up.
    von Podewils F; Lapp S; Wang ZI; Hartmann U; Herzer R; Kessler C; Runge U
    Epilepsy Res; 2014 Sep; 108(7):1221-7. PubMed ID: 24907182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study.
    Villanueva V; Montoya J; Castillo A; Mauri-Llerda JÁ; Giner P; López-González FJ; Piera A; Villanueva-Hernández P; Bertol V; Garcia-Escrivá A; Garcia-Peñas JJ; Garamendi I; Esteve-Belloch P; Baiges-Octavio JJ; Miró J; Falip M; Garcés M; Gómez A; Gil-López FJ; Carreño M; Rodriguez-Uranga JJ; Campos D; Bonet M; Querol R; Molins A; Tortosa D; Salas-Puig J
    Epilepsia; 2018 Sep; 59(9):1740-1752. PubMed ID: 30062784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood vs. juvenile absence epilepsy: How to make a diagnosis.
    Asadi-Pooya AA; Farazdaghi M
    Seizure; 2022 Nov; 102():125-128. PubMed ID: 36223676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure control status and associated factors among pediatric epileptic patients at a neurologic outpatient clinic in Ethiopia.
    Adal HD; Alemu K; Muche EA
    PLoS One; 2021; 16(11):e0259079. PubMed ID: 34731195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of anti-seizure medication (ASM) use in pediatric patients with surgically managed epilepsy: A retrospective review of data from Boston Children's Hospital.
    Wang S; Rotenberg A; Bolton J
    Epilepsy Res; 2020 Feb; 160():106257. PubMed ID: 32004867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy.
    Wirrell EC; Camfield CS; Camfield PR; Gordon KE; Dooley JM
    Neurology; 1996 Oct; 47(4):912-8. PubMed ID: 8857718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualised prediction of drug resistance and seizure recurrence after medication withdrawal in people with juvenile myoclonic epilepsy: A systematic review and individual participant data meta-analysis.
    Stevelink R; Al-Toma D; Jansen FE; Lamberink HJ; Asadi-Pooya AA; Farazdaghi M; Cação G; Jayalakshmi S; Patil A; Özkara Ç; Aydın Ş; Gesche J; Beier CP; Stephen LJ; Brodie MJ; Unnithan G; Radhakrishnan A; Höfler J; Trinka E; Krause R; ; Irelli EC; Di Bonaventura C; Szaflarski JP; Hernández-Vanegas LE; Moya-Alfaro ML; Zhang Y; Zhou D; Pietrafusa N; Specchio N; Japaridze G; Beniczky S; Janmohamed M; Kwan P; Syvertsen M; Selmer KK; Vorderwülbecke BJ; Holtkamp M; Viswanathan LG; Sinha S; Baykan B; Altindag E; von Podewils F; Schulz J; Seneviratne U; Viloria-Alebesque A; Karakis I; D'Souza WJ; Sander JW; Koeleman BPC; Otte WM; Braun KPJ
    EClinicalMedicine; 2022 Nov; 53():101732. PubMed ID: 36467455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial.
    Shinnar S; Cnaan A; Hu F; Clark P; Dlugos D; Hirtz DG; Masur D; Mizrahi EM; Moshé SL; Glauser TA;
    Neurology; 2015 Sep; 85(13):1108-14. PubMed ID: 26311751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the therapeutic response to valproic acid in childhood absence epilepsy through electroencephalogram analysis using machine learning.
    Li SP; Lin LC; Yang RC; Ouyang CS; Chiu YH; Wu MH; Tu YF; Chang TM; Wu RC
    Epilepsy Behav; 2024 Feb; 151():109647. PubMed ID: 38232558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.